14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CION vs CCAP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CION Investment Corporation (CION) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CION carries a Unified Composite Score of 41.8/100 (SELL) at $6.09 (5.4x Forward P/E, 76.3% operating margin), whereas CCAP carries 19.6/100 (STRONG SELL) at $10.07 (7.0x Forward P/E, 78.4% operating margin).
Defensive Composite Rating Caution: Although CION compares more favorably head-to-head, both CION (41.8/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: CION is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.8); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CION vs CCAP. Trailing 12-month operating profitability (CION 76.3% vs CCAP 78.4%) and valuation multiples (CION 5.4x vs CCAP 7.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Asset Management value chain with $296.4M market capitalization and 76.3% operating margin.
OpEx & R&D Reinvestment23.7% of Rev ($55M)
90D Engineering Disclosures0 Published
CCAP Moat ProfileHigh-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $372.1M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment21.6% of Rev ($34M)
90D Engineering Disclosures0 Published
Investor FAQ CION vs CCAP Key Questions & Quantitative Answers
As of Nov 16, 2026, CION Investment Corporation (CION) is the stronger overall head-to-head candidate over Crescent Capital BDC, Inc. (CCAP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CION carries a Unified Composite Score of 41.8/100 (SELL) at $6.09 (5.4x Forward P/E, 76.3% operating margin), whereas CCAP carries 19.6/100 (STRONG SELL) at $10.07 (7.0x Forward P/E, 78.4% operating margin). Defensive Composite Rating Caution: Although CION compares more favorably head-to-head, both CION (41.8/100 SELL) and CCAP (19.6/100 STRONG SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CION is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.8); meanwhile CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CION leads the Growth & Scale pillar: CION posts -4.7% YoY revenue growth and +20.2% YoY earnings growth on $232M TTM revenue (100.0% gross margin, 76.3% operating margin), compared with CCAP at -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin). On trailing 12-month operating scale, CION generates $232M in USD-normalized revenue versus $156M for CCAP. In operating R&D and SG&A reinvestment, CION deploys 23.7% of Rev ($55M) (0 90-day corporate R&D disclosures) versus 21.6% of Rev ($34M) (0 disclosures) for CCAP.
CION screens cheaper on headline valuation multiples. CION trades at 5.4x Forward P/E, 6.8x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (unreported FCF margin), whereas CCAP trades at 7.0x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CION (0.4% ROE) versus CCAP (-0.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CION carries 36.2% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.02β · 42% Vol realized risk). By comparison, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.